Patents by Inventor Robert Warne

Robert Warne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090252738
    Abstract: Compositions and methods useful in inhibiting proliferation of CA IX+preneoplastic or neoplastic cells in a mammal are provided. The compositions are antagonist anti-CA IX antibodies and other inhibitory agents that target carbonic anhydrase activity of CA IX on these cells. The antagonist anti-CA IX antibodies or antigen-binding fragments thereof are specifically reactive with an inhibitory epitope of CA IX or biologically active variant thereof. Formation of an antibody-antigen complex between the antagonist anti-CA IX antibodies or antigen-binding fragments thereof and the respective inhibitory epitopes results in inhibition of carbonic anhydrase activity of CA IX or biologically active variant thereof. Other small molecule agents that inhibit carbonic anhydrase activity of CA IX or biologically active variant thereof and screening assays for identifying such agents are also provided.
    Type: Application
    Filed: August 25, 2003
    Publication date: October 8, 2009
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Justin Wong, Jill Winter, Guita Lalehzadeh, Robert Warne
  • Publication number: 20060292659
    Abstract: A polypeptide containing an anchor region, a protease recognition site, and a detectable signal region can be produced recombinantly and directly attached to a solid support. The polypeptide is useful for screening protease regulators, especially protease inhibitors.
    Type: Application
    Filed: August 1, 2005
    Publication date: December 28, 2006
    Applicant: Chiron Corporation
    Inventors: David Chien, Mark Selby, Kevin Shoemaker, Robert Warne